AnaBios Corporation announces the provision of a $15,000 grant award today for a selected academic scientist conducting translational research. AnaBios provides high-quality human tissue samples from ethically consented organ donors and is committed to enabling human-focused drug discovery in areas of high, unmet medical need, including cardiac disease, chronic pain, respiratory ailments, liver disease and … Read more
An article published in Experimental Biology and Medicine (Volume 246, Issue 6, March, 2021) reports a new nucleic acid-based approach for therapeutics targeting inflammation. The study, led by Dr. Anthony Bell Jr, in the Department of Chemistry and Biochemistry at the University of San Diego in San Diego, CA (USA), reports four novel cruciform DNA ligands that … Read more
Our bodies give us all the clues we need—the trick is reading them correctly. Biomarkers can be thought of as biological indicators of health and disease. They can be detected visually—with or without imaging—or with a test. The global biomarkers market is growing at a significant pace, thanks to new applications of biomarkers as essential tools in … Read more
An article published in Experimental Biology and Medicine (Volume 246, Issue 5, March, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220969844) reports a new therapeutic option for preventing long-term damage to the heart after a heart attack. The study, led by Dr. Y. James Kang, in the Regenerative Medicine Research Center at Sichuan University in Chengdu (China) and the Memphis Institute of … Read more
An article published in Experimental Biology and Medicine (Volume 246, Issue 4, February, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220966296) reports a new mechanism for modulating transforming-growth factor beta (TGF-β) signaling. The study, led by Dr. Thomas Thompson, in the Department of Molecular Genetics, Biochemistry and Microbiology at the University of Cincinnati College of Medicine in Cincinnati, Ohio (USA), proposes a … Read more
Vladimir Potanin donated 500 million rubles ($6.7ml) to the groundbreaking project, aimed for creation of smart materials with pre-programmed properties, allowing development of conceptually new technologies. The project envisages the establishment of a brand-new Laboratory of Programmable Functional Materials in Moscow, Russia, and will be carried out under the leadership of the Nobel laureate Konstantin … Read more
Recent articles in Experimental Biology and Medicine highlight new advances in COVID-19 biology and treatment. In an effort to provide the scientific community with important information on COVID-19, at the rapid pace required to protect our global health care workers and bring useful therapies to end the pandemic, manuscripts are being handled at an accelerated … Read more
The world’s largest integrated community, health management, and real-world data platform PatientsLikeMe announced today it is partnering with Takeda Pharmaceutical Company Limited (“Takeda”). PatientsLikeMe announces a strategic partnership to optimize technology to enhance understanding of the patient experience and improve patients’ ability to partner effectively with their healthcare teams. PatientsLikeMe and Takeda will enhance the … Read more
An article published in Experimental Biology and Medicine (Volume 246, Issue 2, January, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220963755) reports a cell replacement therapy for blindness caused by loss of photoreceptors. The study, led by Dr. Jian Feng, Professor of Physiology and Biophysics, State University of New York at Buffalo in New York (USA), demonstrates that adult human retinal … Read more
An article published in Experimental Biology and Medicine (Volume 246, Issue 1, January, 2021, https://journals.sagepub.com/doi/pdf/10.1177/1535370220961764) describes a new target for the development therapies and vaccines for malaria. The study from the West African Centre for Cell Biology of infectious Pathogens at the University of Ghana in Accra (Ghana) reports that peptide antibodies against a new … Read more
